Zevra Therapeutics (ZVRA) Shares Outstanding (Diluted) (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Weighted Average Shares Outstanding (Diluted) of 61.73 million for Q3 2026, up 10.3% from 55.95 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics posted Weighted Average Shares Outstanding (Diluted) of 57.26 million, up 23.8% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has a five-year compound annual growth rate of 48.4% (FY2020 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 46.25 million in FY2024 (-22.3%), 59.53 million in FY2023 (unchanged), 59.53 million in FY2022 (unchanged) and 59.53 million in FY2021 (+647.7%).
- The Q3 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) since Q3 2021.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last six quarters, with growth averaging 9.3% over the last eight quarters.
- The high point for year-over-year Weighted Average Shares Outstanding (Diluted) in five years was Q1 2022 (growth of 647.7%); the low point was Q2 2024 (a decline of 29.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 61.34 million (Q2 2026), 60.23 million (Q1 2026) and 57.26 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 61.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 61.73 Mn |
| Jun 30, 2026 | 61.34 Mn |
| Mar 31, 2026 | 60.23 Mn |
| Dec 31, 2025 | 57.26 Mn |
| Sep 30, 2025 | 55.95 Mn |
| Jun 30, 2025 | 56.33 Mn |
| Mar 31, 2025 | 54.10 Mn |
| Dec 31, 2024 | 46.25 Mn |
| Sep 30, 2024 | 47.81 Mn |
| Jun 30, 2024 | 41.90 Mn |
| Mar 31, 2024 | 59.53 Mn |
| Dec 31, 2023 | 59.53 Mn |
| Sep 30, 2023 | 59.53 Mn |
| Jun 30, 2023 | 59.53 Mn |
| Mar 31, 2023 | 59.53 Mn |
| Dec 31, 2022 | 59.53 Mn |
| Sep 30, 2022 | 59.53 Mn |
| Jun 30, 2022 | 59.53 Mn |
| Mar 31, 2022 | 59.53 Mn |
| Dec 31, 2021 | 59.53 Mn |
API Access
Zevra Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();